Last updated on: 12/06/2023
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: DAPI
Name of data sourceDeutsches Arzneiprüfungsinstitut
Name under which the data source should be displayed in the inventory (e.g short name if one exists)DAPI database
Name of organisation
1) Department/research groupDAPI
2) Organisation/affiliationDeutsches Arzneiprüfungsinstitut e.V. (DAPI)
Administrative Contact
Title Ms
Last name Werning
First name Johanna
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
Scientific Contact
Title Ms
Last name Werning
First name Johanna
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
Alternative Contact
Title Ms
Last name Kieble
First name Marita
Address line 1Heidestraße 7
Address line 2
Address line 3
CityBerlin
Postcode10557
CountryGermany
2. Description/category
Administrative database, e.g. claims database
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Community / general practice data
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
No events
5. Year of establishment
2005
6. Geographical origin of data
EEA/EFTA countries
Germany
7. Demographical extent of data collection
Nation-wide
8. Age groups
17 years and under [Paediatrics]
18 to 45 years
46 to 64 years
65 years and over
9. Size of the source/catchment population
70,000,000
10 a. Total (cumulative) number of persons with actual data
10 b. Number of persons with active data collection in past calendar year
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
No
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Katzmann JL, Kieble M, Enners S,
Böhm M, Mahfoud F, Laufs U and
Schulz M (2022) Trends in Ezetimibe
Prescriptions as Monotherapy or
Fixed-Dose Combination in Germany
2012–2021.
Front. Cardiovasc. Med. 9:912785.https://doi.org/10.3389/fcvm.2022.912785
Mahfoud, F., Kieble, M., Enners, S. et al. Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-01993-5
Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M. Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiol Drug Saf. 2021;30(11):1493-1503.https://doi.org/10.1002/pds.5324
Enners S, Gradl G, Kieble M, Iliescu OC, Freudewald LG, Said A, Schulz M. Increased Demand for Pharmaceutical Drugs Containing Potassium Iodide In Connection with the Russia-Ukraine Conflict. Pharmazie. 2023, 78: 17-19 https://doi.org/10.1691/ph.2023.2541
Gradl G, Kieble M, Nagaba J, Schulz M. Assessment of the Prescriptions of Systemic Antibiotics in Primary Dental Care in Germany from 2017 to 2021: A Longitudinal Drug Utilization Study. Antibiotics. 2022, 11, 1723https://doi.org/10.3390/antibiotics11121723
